Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer Rupal RamakrishnanDmitry I. Gabrilovich Review 20 February 2013 Pages: 405 - 410
ADAM17-overexpressing breast cancer cells selectively targeted by antibody–toxin conjugates Ahmad TradHinrich P. HansenJoachim Grötzinger Original Article 01 September 2012 Pages: 411 - 421
Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms Lixin ZhangAnda VladOlivera J. Finn Original article 02 September 2012 Pages: 423 - 435
MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients Dana CholujovaJana JakubikovaJan Sedlak Original article 02 September 2012 Pages: 437 - 445
Sinomenine hydrochloride enhancement of the inhibitory effects of anti-transferrin receptor antibody-dependent on the COX-2 pathway in human hepatoma cells Yi HongJuan YangGuanxin Shen Original article 02 September 2012 Pages: 447 - 454
Concomitant combination of active immunotherapy and carboplatin- or paclitaxel-based chemotherapy improves anti-tumor response Y. DiazY. TundidorK. Leon Original Article 02 September 2012 Pages: 455 - 469
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy Yanwen YaoDongmei YuanYong Song Original Article 18 September 2012 Pages: 471 - 479
Up-regulation of Foxp3 participates in progression of cervical cancer Chao ZengYunhong YaoYulan Song Original article 18 September 2012 Pages: 481 - 487
The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study Satwinder Kaur SinghBart TummersSjoerd H. van der Burg Original Article Open access 18 September 2012 Pages: 489 - 501
Mimicking homeostatic proliferation in vitro generates T cells with high anti-tumor function in non-lymphopenic hosts Andrew D. KaiserJules GadiotChristian U. Blank Original article 23 September 2012 Pages: 503 - 515
YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α Ario TakeuchiMasaki ShiotaSeiji Naito Original article 30 September 2012 Pages: 517 - 527
Peripheral CD8+ T cell proliferation is prognostic for patients with advanced thoracic malignancies Melanie J. McCoyAnna K. NowakRichard A. Lake Original article 16 October 2012 Pages: 529 - 539
In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours Raquel MuñozYolanda AriasTomás Girbés Original article 18 October 2012 Pages: 541 - 551
Higher numbers of T-bet+ intratumoral lymphoid cells correlate with better survival in gastric cancer Lu-jun ChenXiao ZhengJing-ting Jiang Original article 23 October 2012 Pages: 553 - 561
Expression of monocyte chemoattractant protein-1 and CC chemokine receptor 2 in non-small cell lung cancer and its significance Xiao-wei ZhangXia QinHui-li Zhu Original article 23 October 2012 Pages: 563 - 570
Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRI Gabrielle M. SiegersEmeline J. RibotPaula J. Foster Original article 26 October 2012 Pages: 571 - 583
The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer Brian M. OlsonLaura E. JohnsonDouglas G. McNeel Original article 30 October 2012 Pages: 585 - 596
Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity Sharon H. ChouAditya V. ShettyGuoxing Zheng Original article 04 November 2012 Pages: 597 - 603
Immunomodulatory activity of SGI-110, a 5-aza-2′-deoxycytidine-containing demethylating dinucleotide Sandra CoralGiulia ParisiMichele Maio Original article 09 November 2012 Pages: 605 - 614
